IP Library Granted Patent US 11,530,301
Granted Patent B2
US 11,530,301 · App. 16/066,810 · Granted Dec 20, 2022

Carbohydrate crosslinker

Inventors: Hotan Mojarradi (Uppsala, SE); Johan Olsson (Bromma, SE); Craig Steven Harris (Biot, FR); Jean-Guy Boiteau (Valbonne, FR); Thibaut Gerfaud (Mouans Sartoux, FR); Loïc Tomas (Biot, FR)
Assignee: Galderma Holding SA
C08J3/075A61K8/042A61K8/73A61K8/735A61K9/0019A61Q19/00C07C209/62C07C213/00C07C269/06C07F7/083C08B37/0063C08B37/0069C08B37/0072C08J3/24C08J7/14C08K5/09C08L5/00C08L5/08C07C2603/18C08J2305/00C08J2305/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,530,301
App. No.
16/066,810
Granted
Dec 20, 2022
Kind
B2
Abstract

The invention relates to a hydrogel product comprising glycosaminoglycan molecules as the swellable polymer, wherein the glycosaminoglycan molecules are covalently crosslinked via crosslinks comprising a spacer group selected from the group consisting of di-, tri-, tetra-, and oligosaccharides.

Claims (19)

1. A process of preparing a hydrogel product comprising crosslinked hyaluronic acid (HA) molecules, the process comprising:

(a) activating carboxyl groups on the HA molecules with a coupling agent to form activated HA molecules;

(b) crosslinking the activated HA molecules via their activated carboxyl groups using diaminotrehalose to obtain crosslinked HA molecules; and

(c) hydrolyzing ester bonds in the crosslinked HA molecules via alkaline hydrolysis to obtain a hydrogel product having less than 50% non-crosslinked HA molecules by weight of the hydrogel product, and

wherein the crosslinked HA molecules are free from synthetic non-carbohydrate structures and synthetic non-carbohydrate linkers.

2. The process according to claim 1 , wherein the crosslinking provides amide bonds between HA molecules and crosslinkers.

3. The process according to claim 1 , wherein the coupling agent is a triazine-based coupling reagent.

4. The process according to claim 1 , wherein hydrolyzing the ester bonds comprises swelling the crosslinked HA molecules in an alkaline solution for at least 1 hour.

5. The process according to claim 4 , further comprising:

(d) neutralizing the crosslinked HA molecules to a neutral pH;

(e) precipitating the neutralized crosslinked HA molecules;

(f) drying the precipitated crosslinked HA molecules; and

(g) swelling the dried crosslinked HA molecules in a phosphate buffer.

6. The process according to claim 1 , wherein (a) and (b) occur simultaneously.

7. The process according to claim 4 , wherein the alkaline solution comprises a hydroxide.

8. The process according to claim 1 , wherein less than 20% by weight of the hydrogel product obtained in (c) comprises HA molecules that are not crosslinked.

9. The process according to claim 1 , wherein the crosslinked HA molecules are in the form of gel particles.

10. The process according to claim 9 , wherein the gel particles are 0.01 mm to 1 mm in size.

11. The process according to claim 1 , wherein the HA molecules, prior to crosslinking, have a molecular weight of about 1,000 kDa.

Assignments (5)
CHANGE OF ADDRESS Recorded Jun 27, 2022
From: GALDERMA HOLDING SA
To: GALDERMA HOLDING SA
Reel/Frame 061113/0710 →
ASSET TRANSFER AGREEMENT Recorded Oct 3, 2021
From: GALDERMA S.A.
To: NESTLÉ SKIN HEALTH S.A.
Reel/Frame 057698/0295 →
CHANGE OF NAME Recorded Oct 3, 2021
From: NESTLÉ SKIN HEALTH S.A.
To: GALDERMA HOLDING SA
Reel/Frame 057698/0356 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2020
From: GERFAUD, THIBAUT; TOMAS, LOIC
To: GALDERMA S.A.
Reel/Frame 053360/0765 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2018
From: MOJARRADI, HOTAN; OLSSON, JOHAN; HARRIS, CRAIG STEVEN; BOITEAU, JEAN-GUY
To: GALDERMA S.A
Reel/Frame 047101/0374 →
Priority Claims (4)
EP 15202944 · Dec 29, 2015 · regional
EP 16172225 · May 31, 2016 · regional
EP 16172241 · May 31, 2016 · regional
EP 16172254 · May 31, 2016 · regional
Continuity (1)
Related Publication 20190023812A1 · Jan 24, 2019
Cited By (4)
US 12,365,768 US 12,540,219 US 12,667,534 US 12,673,131